Literature DB >> 25667371

The low-dose ACTH stimulation test: is 30 minutes long enough?

Julia Cartaya, Madhusmita Misra.   

Abstract

OBJECTIVE: Controversy persists regarding the use of the low-dose adrenocorticotropic hormone (ACTH) stimulation test (LDST) for the diagnosis of adrenal insufficiency (AI) and optimal test result interpretation. However, many centers are now using the LDST to assess cortisol secretion adequacy, and some only use a 30-minute cortisol level to determine adrenal sufficiency or AI. This study examined both 30- and 60-minute cortisol levels to assess whether the interpretation of the test was affected when both cortisol levels were taken into consideration.
METHODS: Data were obtained by retrospective chart review from a single pediatric endocrinology unit over a 7-year period. We identified 82 patients who completed the LDST. Their mean age was 11.7 years, and 37% were female. Cortisol levels were evaluated at baseline and 30 and 60 minutes after cosyntropin administration. A cutoff value ≥18 μg/dL was used to define adrenal sufficiency.
RESULTS: We found that 54% of patients reached peak cortisol levels at 60 minutes, and 11 patients who did not pass the test at 30 minutes did so at 60 minutes. The only predictive characteristic was weight status; overweight and obese individuals tended to peak at 30 minutes, and normal and underweight individuals tended to peak at 60 minutes.
CONCLUSION: Although further studies are necessary to confirm our findings, it appears that measuring cortisol both 30 and 60 minutes following synthetic ACTH administration may be necessary to avoid overdiagnosing AI.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25667371      PMCID: PMC4442480          DOI: 10.4158/EP14423.OR

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


  17 in total

1.  Adrenocorticotropin stimulation test: effects of basal cortisol level, time of day, and suggested new sensitive low dose test.

Authors:  G Dickstein; C Shechner; W E Nicholson; I Rosner; Z Shen-Orr; F Adawi; M Lahav
Journal:  J Clin Endocrinol Metab       Date:  1991-04       Impact factor: 5.958

2.  CDC growth charts: United States.

Authors:  R J Kuczmarski; C L Ogden; L M Grummer-Strawn; K M Flegal; S S Guo; R Wei; Z Mei; L R Curtin; A F Roche; C L Johnson
Journal:  Adv Data       Date:  2000-06-08

3.  Use of the low-dose corticotropin stimulation test for the diagnosis of secondary adrenocortical insufficiency.

Authors:  C H Choi; S C Tiu; C C Shek; K L Choi; F K W Chan; P S Kong
Journal:  Hong Kong Med J       Date:  2002-12       Impact factor: 2.227

4.  Standard and low-dose short adrenocorticotropin test compared with insulin-induced hypoglycemia for assessment of the hypothalamic-pituitary-adrenal axis in children with idiopathic multiple pituitary hormone deficiencies.

Authors:  N Weintrob; E Sprecher; Z Josefsberg; C Weininger; Y Aurbach-Klipper; D Lazard; M Karp; A Pertzelan
Journal:  J Clin Endocrinol Metab       Date:  1998-01       Impact factor: 5.958

5.  The low-dose ACTH test does not provide a useful assessment of the hypothalamic-pituitary-adrenal axis in secondary adrenal insufficiency.

Authors:  Abdulwahab M Suliman; Thomas P Smith; Mourad Labib; Tarek M Fiad; T Joseph McKenna
Journal:  Clin Endocrinol (Oxf)       Date:  2002-04       Impact factor: 3.478

6.  Presentation of primary adrenal insufficiency in childhood.

Authors:  Susan Hsieh; Perrin C White
Journal:  J Clin Endocrinol Metab       Date:  2011-04-06       Impact factor: 5.958

7.  A low dose ACTH test to assess the function of the hypothalamic-pituitary-adrenal axis.

Authors:  S Rasmuson; T Olsson; E Hagg
Journal:  Clin Endocrinol (Oxf)       Date:  1996-02       Impact factor: 3.478

8.  The role of the low dose (1 microgram) adrenocorticotropin test in the evaluation of patients with pituitary diseases.

Authors:  K Tordjman; A Jaffe; N Grazas; C Apter; N Stern
Journal:  J Clin Endocrinol Metab       Date:  1995-04       Impact factor: 5.958

Review 9.  Diagnosis of adrenal insufficiency.

Authors:  Richard I Dorin; Clifford R Qualls; Lawrence M Crapo
Journal:  Ann Intern Med       Date:  2003-08-05       Impact factor: 25.391

10.  Frequency of hypoglycemia in children with adrenal insufficiency.

Authors:  E Artavia-Loria; J L Chaussain; P F Bougnères; J C Job
Journal:  Acta Endocrinol Suppl (Copenh)       Date:  1986
View more
  6 in total

1.  Assessment of the HPA Axis: Another New Test?

Authors:  Ashley Grossman
Journal:  Endocrine       Date:  2015-09-11       Impact factor: 3.633

2.  Performance of low-dose cosyntropin stimulation test handled via plastic tube.

Authors:  Leonard Saiegh; Asala Abu-Ahmad; Mohammad Sheikh-Ahmad; Maria Reut; Limor Chen-Konak; Nizar Jiries; Carmela Shechner
Journal:  Endocrine       Date:  2017-05-22       Impact factor: 3.633

3.  Diagnosis of adrenal insufficiency in eosinophilic esophagitis: The importance of timing of cortisol measurements in interpreting low-dose adrenocorticotropic hormone stimulation testing.

Authors:  Melissa J Schoelwer; Todd D Nebesio
Journal:  J Pediatr       Date:  2016-05-14       Impact factor: 4.406

4.  Morning cortisol as an alternative to Short Synecthan test for the diagnosis of primary adrenal insufficiency.

Authors:  Imran Ulhaq; Tauseef Ahmad; Adeel Khoja; Najmul Islam
Journal:  Pak J Med Sci       Date:  2019 Sep-Oct       Impact factor: 1.088

Review 5.  Emergency management of adrenal insufficiency in children: advocating for treatment options in outpatient and field settings.

Authors:  Bradley S Miller; Sandra P Spencer; Mitchell E Geffner; Evgenia Gourgari; Amit Lahoti; Manmohan K Kamboj; Takara L Stanley; Naveen K Uli; Brandy A Wicklow; Kyriakie Sarafoglou
Journal:  J Investig Med       Date:  2019-02-28       Impact factor: 2.895

6.  Morning Serum Cortisol as a Predictor for the HPA Axis Recovery in Cushing's Disease.

Authors:  Q Cui; D Liu; B Xiang; Q Sun; L Fan; M He; Y Wang; X Zhu; H Ye
Journal:  Int J Endocrinol       Date:  2021-09-03       Impact factor: 3.257

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.